Biomarker

Home
Podcast
Archive
About
New
Top
Discussion
Time BioVentures: D.A. Wallach
“I love technology. I love learning about new algorithms. But at the end of the day, we just want to solve problems.”
 • 
Dylan Neel
EpiBiologics: Rami Hannoush
"We came together with a unified vision to build EpiBiologics as a pioneering company in the extracellular degradation space."
 • 
Dylan Neel
A Tale of Two Incretins
The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity
 • 
Dylan Neel
, 
Kirti Nath
, and 
Harim Won
April 2023
Lab Meeting: Daniel Drucker
“You only get better by being challenged, and listening to really important ideas.”
 • 
Dylan Neel
1
Vida Ventures: Stefan Vitorovic
“If you treat people well, work hard and stick to your principles, things will work out.”
 • 
Dylan Neel
March 2023
Foundery: Max Krummel & Michel Streuli
“We are trying to drive discovery that matters.”
 • 
Dylan Neel
23 Biotech VCs in '23
Rising stars in biotech investing and creation discuss how they got started, lessons learned, tips to break into the industry and what they love about…
 • 
Dylan Neel
2
Lab Meeting: Peter Zandstra
“Asking the big question is always worthwhile.”
 • 
Dylan Neel
February 2023
Transcera: Hunter Goble, CEO
"For us, storytelling has been critical."
 • 
Dylan Neel
Vida Ventures: Arjun Goyal
"Coming to the US was about impact—so that my efforts would lead to a medicine that helps patients.”
 • 
Dylan Neel
Nektar: Robert Chess
"Entrepreneurs should embrace the fact that they're starting at a tough time and view it as a long-term advantage."
 • 
Dylan Neel
 and 
Henry Klingenstein
Lab Meeting: Bruce Walker
“I think the next 20 years are going to be the age of immunotherapy.”
 • 
Dylan Neel
© 2023 Dylan Neel
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing